![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/immunic-appoints-jason-tardio-as-chief-operating-officer-and-president-302191871.html
https://www.prnewswire.com/news-releases/immunic-to-participate-in-industry-and-scientific-conferences-in-june-302156368.html
https://www.prnewswire.com/news-releases/immunic-inc-to-announce-financial-results-for-the-first-quarter-ended-march-31-2024-and-provide-corporate-update-302132743.html
https://www.prnewswire.com/news-releases/immunic-to-host-ms-rd-day-and-participate-in-investor-conferences-in-april-302107242.html
https://www.prnewswire.com/news-releases/immunic-receives-notice-of-allowance-for-composition-of-matter-patent-of-a-specific-polymorph-of-vidofludimus-calcium-in-the-united-states-302093964.html
https://www.prnewswire.com/news-releases/immunic-presents-data-from-phase-2-calliper-and-calvid-1-trials-of-vidofludimus-calcium-at-the-actrims-forum-2024-302073978.html
https://www.prnewswire.com/news-releases/immunic-inc-to-announce-financial-results-for-the-year-ended-december-31-2023-and-provide-corporate-update-302061844.html
https://www.prnewswire.com/news-releases/immunic-highlights-2023-accomplishments-and-upcoming-milestones-302027066.html
https://www.prnewswire.com/news-releases/immunic-inc-announces-private-placement-of-up-to-240-million-302027065.html
https://www.prnewswire.com/news-releases/immunic-to-announce-financial-results-for-the-third-quarter-ended-september-30-2023-and-provide-corporate-update-301979620.html